Date Filed | Type | Description |
01/09/2018 |
4
| THOMPSON JOHN CRAIG (President & CEO) has filed a Form 4 on Anthera Pharmaceuticals Inc
Txns:
| Granted 1,847,074 options to buy
@ $1.65, valued at
$3M
|
|
09/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/07/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
09/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/03/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
02/06/2017 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
12/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/10/2015 |
4
| THOMPSON JOHN CRAIG (COO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns:
| Sold 10,000 shares
@ $44.08, valued at
$440.8k
Exercised 10,000 options to buy
@ $14.45, valued at
$144.5k
|
|
08/07/2015 |
4
| THOMPSON JOHN CRAIG (COO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns:
| Sold 10,000 shares
@ $46.31, valued at
$463.1k
Exercised 10,000 options to buy
@ $14.45, valued at
$144.5k
|
|
07/08/2015 |
4
| THOMPSON JOHN CRAIG (COO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns:
| Sold 10,000 shares
@ $47.91, valued at
$479.1k
Exercised 10,000 options to buy
@ $14.45, valued at
$144.5k
|
|
06/16/2015 |
4
| THOMPSON JOHN CRAIG (COO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns:
| Sold 10,000 shares
@ $41.51, valued at
$415.1k
Exercised 10,000 options to buy
@ $14.45, valued at
$144.5k
|
|
06/10/2015 |
4
| THOMPSON JOHN CRAIG (COO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns:
| Sold 11,862 shares
@ $43.5, valued at
$516k
Sold 10,637 shares
@ $43, valued at
$457.4k
Exercised 22,499 options to buy
@ $14.45, valued at
$325.1k
|
|
05/19/2015 |
4
| THOMPSON JOHN CRAIG (COO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns:
| Sold 30,000 shares
@ $39.63, valued at
$1.2M
Exercised 30,000 options to buy
@ $14.45, valued at
$433.5k
|
|
01/09/2015 |
4
| THOMPSON JOHN CRAIG (COO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns:
| Granted 100,000 options to buy
@ $39.94, valued at
$4M
|
|
02/05/2014 |
4
| THOMPSON JOHN CRAIG (COO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns:
| Granted 250,000 options to buy
@ $14.45, valued at
$3.6M
|
|
09/13/2013 |
4
| THOMPSON JOHN CRAIG (Chief Commercial Officer) has filed a Form 4 on Trius Therapeutics Inc
Txns:
| Disposed/sold 2,455 shares
@ $0 Disposed/sold 150,000 options to buy
@ $4.3, valued at
$645k
Disposed/sold 90,000 options to buy
@ $4.8, valued at
$432k
Disposed/sold 125,000 options to buy
@ $6.13, valued at
$766.3k
|
|
03/11/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/12/2012 |
4
| THOMPSON JOHN CRAIG (Chief Commercial Officer) has filed a Form 4 on Trius Therapeutics Inc
Txns:
| Granted 90,000 options to buy
@ $4.8, valued at
$432k
|
|
01/11/2011 |
4
| THOMPSON JOHN CRAIG (Chief Commercial Officer) has filed a Form 4 on Trius Therapeutics Inc
Txns:
| Granted 150,000 options to buy
@ $4.3, valued at
$645k
|
|
01/11/2011 |
3
| THOMPSON JOHN CRAIG (Chief Commercial Officer) has filed a Form 3 on Trius Therapeutics Inc |